Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data - Zhao, Quanfeng; Ma, Pan; Fu, Peishu; Wang, Jiayu; Wang, Kejing; Chen, Lin; Yang, Yang (Frontiers in Pharmacology, 2022)